Lewis Ho is recognized as one of the leading IP and transactional attorneys in Asia focusing in the life sciences sector. He helps pharmaceutical and biotechnology companies and their financial sponsors to capture, manage, risk assess, evaluate and monetize their intellectual property assets.

Lewis has extensive experience advising on both inbound and outbound transactions, and he has negotiated more than 120 M&A, collaboration, outsourcing, joint venture, licensing and financing (including IPO) deals.

He spearheaded the establishment of the GSK R&D Centre in Shanghai, one of the first and largest projects of its kind in China.